.png)
Principal Investigator
Rogelio O. Bardinas, MD, FAAFP - Family Medicine
Dr. Rogelio O. Bardinas, MD, FAAFP is a board-certified Family Medicine physician and accomplished Clinical Investigator with over 30 years of international medical and research experience. He currently serves as Medical Director at MAS Health Center and Principal Investigator at Alma Clinical Research Center, where he oversees a wide range of Phase II and III clinical trials in collaboration with leading global pharmaceutical sponsors. Dr. Bardinas has led more than 50 FDA-regulated studies across therapeutic areas including respiratory disease, endocrinology, neurology, infectious disease, and pain management, contributing to the development of innovative treatments that improve patient care worldwide. His background spans family medicine, orthopedics, and trauma surgery, with prior leadership roles at Cano Health, Sanitas Research, and Baptist Health South Florida. Combining extensive clinical experience with a deep commitment to medical advancement, Dr. Bardinas is recognized for his leadership in advancing evidence-based medicine and improving outcomes for diverse patient populations.
Principal Investigator
Gustavo G. Leon, MD - General Sugeon / Clinical Instructor
Dr. Gustavo G. Leon is a board-certified general surgeon and seasoned clinical researcher with more than 40 years of medical experience and over 15 years of involvement in industry-sponsored clinical trials. He has served as Principal Investigator and Sub-Investigator on a broad range of Phase I–III studies across neurology, psychiatry, endocrinology, rheumatology, dermatology, renal disease, infectious disease, respiratory disorders, and gastrointestinal conditions.
Dr. Leon has worked with multiple high-volume research organizations and academic institutions, contributing to early-phase pharmacokinetic studies, complex therapeutic trials, and long-term safety and efficacy programs. Known for his strong adherence to GCP, FDA, and ICH guidelines, he brings rigorous clinical oversight and a commitment to advancing new therapies through high-quality research.
Principal Investigator
Olga L. Mendoza, MD - Family Medicine
Dr. Olga L. Mendoza is an experienced Principal Investigator and Medical Director with more than 30 years of clinical practice and extensive expertise in conducting Phase II–IV clinical trials. Her research background spans respiratory and infectious diseases, chronic and metabolic conditions, psychiatric and behavioral health disorders, dermatology, pharmacogenomics, and vaccine development. Dr. Mendoza has led and supported numerous industry-sponsored studies with global sponsors including Pfizer, Eli Lilly, Novo Nordisk, Sanofi, and Roche.
Highly skilled in GCP/ICH compliance, FDA-regulated research, safety reporting, and site operations, Dr. Mendoza brings strong leadership in trial oversight, multidisciplinary team coordination, and regulatory excellence. Her hands-on technical proficiency includes EDC and IWRS systems, IP management, psychiatric rating scales, ECG/spirometry procedures, and IATA-compliant sample handling. Committed to high-quality, patient-centered research, she ensures that every study under her direction meets the highest standards of accuracy, safety, and operational performance.
Principal Investigator
Jorge Borges, D.M.D - General Dentist, Prosthodontics Specialist
Dr. Jorge Borges is an accomplished General Dentist and Prosthodontics Specialist with more than 40 years of clinical experience in restorative, implant, aesthetic, and prosthetic dentistry. He has owned and operated multiple successful dental practices, providing comprehensive oral rehabilitation and advanced restorative care to diverse patient populations. Dr. Borges’ expertise includes implant restorations, fixed and removable prosthetics, cosmetic dentistry, and long-term management of complex oral health conditions.
Trained in both the United States and Cuba, he holds a D.M.D. from Nova Southeastern University and advanced specialty training in prosthetic dentistry. Fully bilingual in English and Spanish, Dr. Borges brings strong clinical judgment, exceptional technical skill, and decades of hands-on experience to every patient he serves. His background as a practice owner and prosthetic specialist reflects a deep commitment to high-quality, compassionate dental care.
Sub Investigator
Harold Iparraguirre, APRN, FMD
Harold Iparraguirre, APRN, FMD, is an experienced Advanced Practice Registered Nurse and clinical research professional with more than a decade of combined medical and research experience. Trained as an Internal Medicine physician internationally and certified as an APRN in the United States, he has served as a Sub-Investigator and Clinical Research Coordinator across a wide range of Phase 2 and Phase 3 studies.
His research background includes infectious diseases, COVID-19 therapeutics and prevention, respiratory medicine, metabolic disorders, hepatology, dermatology, and chronic disease management, with hands-on experience supporting trials from sponsors such as Shionogi, Gilead, GSK, Vir Biotechnology, and others. Harold is skilled in patient assessments, informed consent, protocol implementation, EDC/IWRS systems, safety reporting, and visit procedures, ensuring high-quality and compliant study conduct. Fully bilingual in English and Spanish, he brings clinical depth, strong regulatory knowledge, and a patient-centered approach to every research project he supports.
Principal Investigator
Isaac Levy, MD - Hematology & Oncology
Dr. Isaac Levy is a board-certified Hematologist and Oncologist with more than 30 years of clinical experience and an extensive background in industry-sponsored oncology research. He has led and contributed to numerous Phase I–IV clinical trials across breast cancer, prostate cancer, lung cancer, multiple myeloma, myeloproliferative disorders, supportive care, and translational biomarker research. Dr. Levy has served as a Principal Investigator on major global studies sponsored by Eli Lilly, Novartis, Merck, Pfizer, Sanofi, GSK, Incyte, and more, bringing deep therapeutic expertise and strong command of complex oncology protocols.
Trained at the University of Miami and Fred Hutchinson Cancer Center, Dr. Levy has maintained a long-standing private practice in hematology and oncology while actively engaging in clinical research, advisory boards, and continuing medical education with leading cancer institutions. His experience spans advanced therapeutics, immunotherapy, targeted agents, and biomarkers, positioning him as a highly respected investigator within the oncology research community.
Principal Investigator
Juan A. Dorado, MD F A C P - Internal Medicine
Dr. Juan A. Dorado, MD, FACP, is a board-certified Internal Medicine physician with extensive experience in hospital medicine, hospice and palliative care, and academic teaching. He currently serves as an Academic Hospitalist at HCA Florida Kendall Hospital and provides specialized end-of-life care through multiple hospice organizations, including VITAS Healthcare, Catholic Health Services, and Bristol Hospice. In addition, he is a Clinical Assistant Professor of Internal Medicine at Nova Southeastern University and HCA Florida Kendall Hospital, where he contributes to medical education and mentorship.
Dr. Dorado earned his medical degree from Ross University School of Medicine and completed his Internal Medicine residency at Florida State University College of Medicine, where he gained experience presenting clinical research and leading educational seminars. He is a Diplomate of the American Board of Internal Medicine and a Fellow of the American College of Physicians, recognized for his excellence in clinical care and commitment to high professional standards. In 2025, he received the Physician Excellence Award from HCA Florida Kendall Hospital.
In addition to his clinical and academic roles, Dr. Dorado is active in health policy advocacy through the American College of Physicians and has authored multiple clinical presentations and case reports covering endocrinology, cardiology, geriatrics, infectious diseases, and rare conditions. Fluent in evidence-based medicine and dedicated to compassionate patient care, he brings strong leadership and clinical expertise to every healthcare setting he serves.